Skip to content
LCMS Limited Logo
919-201-0047Contact
LCMS Limited Logo
  • Home
  • About LCMS Limited
  • Training
  • Solutions
    • Food Allergen Research
    • Cross-Contamination Facility testing
    • Preclinical and Early Discovery
    • Monoclonal Antibody Measurements
    • Exosome and Serum Analysis
    • Impurity Detection
    • Training
    • Expert Witness
  • Science
  • News & Events
  • Contact

LCMS Limited received a contract to screen for b-lactam

Posted on January 30, 2023January 30, 2023 by admin

LCMS Limited received a contract to screen for b-lactam contamination in Chemical to Materials and Cell Culture Products.

Posted in News

Quantitate nut allergens in oral immune therapy formulations

Posted on January 30, 2023January 30, 2023 by admin

LCMS Limited received multiple contracts to characterize and quantitate nut allergens in oral immune therapy formulations by trypsin digestion with LC/MS/MS for Aimmune Therapeutics . In addition LCMS Limited is performing stability studies on the formulations and developing and determining blend uniformity.

Posted in News

Contract for B-lactam decontaminations

Posted on January 30, 2023January 30, 2023 by admin

LCMS Limited together with ClorDySys received a contract for B-lactam decontaminations of a manufacturing facility and the equipment being converted for vaccine production.

Posted in News
Logo 919-201-0047 robert_voyksner@LCMSLimited.com 1502 West NC-54, Suite 504
Durham, NC, 27707
©2023 LCMS LIMITED | DESIGN AND DEVELOPMENT BY PENNER WEB DESIGN